Skip to main content
Apogee Therapeutics, Inc. logo

Apogee Therapeutics, Inc. — Investor Relations & Filings

Ticker · APGE ISIN · US03770N1019 US Manufacturing
Open in API
Filings indexed 235 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country US United States of America
Listing US APGE

About Apogee Therapeutics, Inc.

https://apogeetherapeutics.com/

Apogee Therapeutics, Inc. is a clinical-stage biotechnology company that develops differentiated biologics for immunological and inflammatory (I&I) diseases. The company's pipeline consists of novel antibody therapeutics targeting well-established biological pathways to treat conditions such as atopic dermatitis (AD), asthma, and chronic obstructive pulmonary disease (COPD), as well as other dermatological and respiratory disorders. Apogee's scientific approach focuses on creating therapies with the potential for improved efficacy and less frequent dosing, aiming to advance the standard of care for patients with these conditions.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 88% confidence The document is a Current Report on Form 8-K filed with the SEC, detailing the Item 1.01 material definitive agreement and Item 7.01 FD disclosure. It does not contain full financial statements or earnings results but is a regulatory filing under the Exchange Act. This falls under the general “Regulatory Filings” category rather than a specific report like an earnings release or annual report.
2026-05-27 English
FORM 8-K
Regulatory Filings Classification · 90% confidence The document is a U.S. SEC Form 8-K current report disclosing clinical data and a press release/presentation under Regulation FD. It is not a full annual or interim report, not an earnings release, and contains no financial statements. It serves as a regulatory filing under the Exchange Act without fitting any more specific category, so it falls into the fallback “Regulatory Filings” classification.
2026-05-27 English
10-Q - Apogee Therapeutics, Inc. (0001974640) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-11 English
8-K - Apogee Therapeutics, Inc. (0001974640) (Filer)
Report Publication Announcement Classification · 92% confidence The document is a Form 8-K current report (SEC filing) that does not itself include substantive financial statements or analysis but instead notes that an Earnings Press Release is being furnished as Exhibit 99.1. It is under 5,000 characters and states that the report is attached as an exhibit. Per the “menu vs. meal” rule, this is a report publication announcement rather than the financial report itself.
2026-05-11 English
ARS - Apogee Therapeutics, Inc. (0001974640) (Filer)
Annual Report
2026-04-24 English
4 - Apogee Therapeutics, Inc. (0001974640) (Issuer)
Director's Dealing
2026-03-28 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.